Effect of Endothelin-Receptor Antagonists on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage Remains Unclear

被引：9

作者：

Vergouwen, Mervyn D. I. ^{[1
]}

机构：

[1] Univ Toronto, Toronto Western Hosp, Div Neurol, Dept Med, Toronto, ON M5T 2S8, Canada

来源：

STROKE | 2009年 / 40卷 / 12期

关键词：

D O I：

10.1161/STROKEAHA.109.565887

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

引用

页码：E714 / E714

页数：1

共 4 条

[1]

Do Endothelin-Receptor Antagonists Prevent Delayed Neurological Deficits and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage? A Meta-Analysis [J].

Kramer, Andreas ;

Fletcher, Jeffrey .

STROKE, 2009, 40 (10) :3403-3406

[2]

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial [J].

Macdonald, R. Loch ;

Kassell, Neal F. ;

Mayer, Stephan ;

Ruefenacht, Daniel ;

Schmiedek, Peter ;

Weidauer, Stephan ;

Frey, Aline ;

Roux, Sebastien ;

Pasqualin, Alberto .

STROKE, 2008, 39 (11) :3015-3021

[3]

Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage [J].

van der Schaaf, IC ;

Ruigrok, YM ;

Rinkel, GJE ;

Algra, A ;

van Gijn, J .

STROKE, 2002, 33 (08) :2043-2046

[4]

DEFINITION OF INITIAL GRADING, SPECIFIC EVENTS, AND OVERALL OUTCOME IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE - A SURVEY [J].

VANGIJN, J ;

BROMBERG, JEC ;

LINDSAY, KW ;

HASAN, D ;

VERMEULEN, M .

STROKE, 1994, 25 (08) :1623-1627

← 1 →